CSI Market
Sign In | Register

Applied Genetic Technologies (AGTC) Annual Income Statement

Annual · GAAP · USD millions
Access AGTC quarterly income statements →
Income statement data covering Applied Genetic Technologies–Jun 30 2018 offers a view into how Jun 30 2022's operating results have moved alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jun 30 2022)
2022 		(Jun 30 2021) (Jun 30 2020) (Jun 30 2019) (Jun 30 2018)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax0.33
Total Revenue0.33
Costs & Expenses
Gross Profit0.33
Selling, Administration, Marketing16.99
Research and Development Expense49.52
Other Operating Expense / -Income0.00
Total operating costs including COS66.50
Operating income / -loss-66.18
Interest Expense2.67
Net Interest (-)Expense / Income-2.67
Loss / -Gain on Investment0.00
Other loss / -income-0.10
Total costs & expenses69.08
Income & Taxes
Income / -loss before income taxes-68.75
Income taxes expenses / -benefit0.00
Income after income taxes-68.94
Net income / -loss of other equity-0.19
Income / -loss from continuing operations-68.94
Net income / -loss-68.94
Income / -loss to shareholder-68.94
EBIT-66.08
EBITD-64.94
EBITDA-64.43
Earnings Per Share
Basic EPS (excl. extra items)-1.53
Basic Net EPS-1.53
Basic shares outstanding (Mill. of Units)45.03
Diluted Net EPS-1.53
Diluted average shares (Mill. of Units)45.03
4 historic quarters locked

Sign in to unlock the full Applied Genetic Technologies income statement history.

Sign In Create Free Account

About AGTC Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.